179 related articles for article (PubMed ID: 9846499)
1. Pulmonary metastases of breast carcinomas: ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival.
Kayser K; Biechele U; Kayser G; Dienemann H; Andrè S; Bovin NV; Gabius HJ
J Surg Oncol; 1998 Nov; 69(3):137-46. PubMed ID: 9846499
[TBL] [Abstract][Full Text] [Related]
2. Primary colorectal carcinomas and their intrapulmonary metastases: clinical, glyco-, immuno- and lectin histochemical, nuclear and syntactic structure analysis with emphasis on correlation with period of occurrence of metastases and survival.
Kayser K; Zink S; André S; Schüring MP; Hecker E; Klar E; Bovin NV; Kaltner H; Gabius HJ
APMIS; 2002 Jun; 110(6):435-46. PubMed ID: 12193204
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
4. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
5. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary metastases of breast cancer. When is resection indicated?
Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
[TBL] [Abstract][Full Text] [Related]
7. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
8. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.
Rosen PP; Kimmel M
Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331
[TBL] [Abstract][Full Text] [Related]
9. The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor.
Mustac E; Melato M; Sasso F; Valkovic T; Bottin C; Jonjic N
J Cancer Res Clin Oncol; 1996; 122(11):693-7. PubMed ID: 8898981
[TBL] [Abstract][Full Text] [Related]
10. Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation.
Bossuyt V; Fadare O; Martel M; Ocal IT; Burtness B; Moinfar F; Leibl S; Tavassoli FA
Int J Surg Pathol; 2005 Oct; 13(4):319-27. PubMed ID: 16273187
[TBL] [Abstract][Full Text] [Related]
11. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
Briffod M; Hacène K; Le Doussal V
Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
[TBL] [Abstract][Full Text] [Related]
14. Association of prognosis in surgically treated lung cancer patients with cytometric, histometric and ligand histochemical properties: with an emphasis on structural entropy.
Kayser K; Kayser G; Eichhorn S; Biechele U; Altiner M; Kaltner H; Zeng FY; Vlasova EV; Bovin NV; Gabius HJ
Anal Quant Cytol Histol; 1998 Aug; 20(4):313-20. PubMed ID: 9739414
[TBL] [Abstract][Full Text] [Related]
15. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
[TBL] [Abstract][Full Text] [Related]
17. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
18. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections.
Tot T
Cancer; 2007 Dec; 110(11):2551-60. PubMed ID: 17932896
[TBL] [Abstract][Full Text] [Related]
20. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
